Abiopharma

🔍 Natarajan Rajesh (Executive)

Company: HEALTHEQUITY, INC. (HQY)

Report Date: 2026-06-25

Detailed Transactions and Holdings:

• Acquired 2,877 shares of Common Stock (Direct)
  Date: 2026-06-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 18,130.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest in full on the earlier of; (i) June 25, 2027, or (ii) the date of the issuer's next annual stockholder meeting in June 2027. Vested shares will be delivered to the reporting person on the earlier of February 1, 2033, a change of control of the issuer (as defined in the issuer's Amended and Restated 2024 Equity Incentive Plan), or the reporting person's termination of service (as defined in the issuer's Amended and Restated 2024 Equity Incentive Plan), or the reporting person's death.
• REMARKS: The Power of Attorney given by Mr. Natarajan was previously filed with the U.S. Securities and Exchange Commission on June 26, 2023, as an exhibit to a statement on Form 4 filed by Mr. Natarajan with respect to HealthEquity, Inc. and is hereby incorporated by reference.